Navigation Links
Bioniche Phase III Clinical Trial with Urocidin(TM) Given Continued Green Light by DMC
Date:8/24/2009

muscle-invasive bladder cancer.

In September, 2007, the Company announced that an agreement had been reached with the FDA under the Special Protocol Assessment (SPA) procedure on the design of the trial, including its endpoints, data analysis and conduct. It provides assurance that, if the trial endpoints are met, they will serve as the basis for product approval under a Biologics Licensing Application (BLA). An SPA gives a clear pathway to registration of Urocidin when the trial endpoints are achieved. This indication for MCC received Fast Track designation by the FDA last year.

About Bladder Cancer

In North America, bladder cancer is the fourth most common cancer in men and in the top ten for women. In the United States, approximately 70,000 patients are newly diagnosed with bladder cancer each year. In addition, the cancers of many previously-diagnosed patients remain unresolved, sometimes leading to cystectomy (bladder removal) or death. Approximately 70 percent of bladder cancer patients have the non-muscle-invasive form of bladder cancer at diagnosis and, on appropriate regulatory approvals, might be eligible for multiple treatments with Urocidin.

Non-muscle-invasive bladder cancer is a form of bladder cancer localized in the surface layers of the bladder that has not yet spread into the deeper muscle layer. This form of bladder cancer is treated predominantly by urologists using surgical resection and intravesical infusion therapy. Urocidin is an intravesical infusion therapy, administered via trans-urethral catheter into the bladder.

About Urocidin(TM)

Urocidin is a formulation of MCC, a sterile mycobacterial cell wall-DNA complex composition that has a dual mode of action: immune stimulation and direct anticancer activity. Urocidin is formulated for the treatment of bladder cancer, where it is administered by trans-urethral catheter directly into the bladder, coming into con
'/>"/>

SOURCE Bioniche Life Sciences Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Bioniche Repays Revolving Credit Facility
2. Bioniche Provides a Corporate Update
3. Bioniche Pharma and Synerx Pharma Launch Melphalan Hydrochloride for Injection
4. Bioniche Represented at House of Commons Sub-Committee on Food Safety
5. Bioniche Phase III Clinical Trial with Urocidin(TM) Progressing Well
6. Bioniche Reports Fiscal 2009 Third Quarter
7. Bioniche Provides a Corporate Update
8. Bioniche Completes Recruitment in First Phase III Clinical Trial with Urocidin(TM)
9. Bioniche Revolving Credit Facility Maturity Date Amended
10. Bioniche Phase II Bladder Cancer Trial Results Published in The Journal of Urology
11. Bioniche Warrants Expiration Date to be Extended
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2015)... Raton, Fl (PRWEB) , ... August 30, 2015 ... ... that Executive Vice President Jeff Fernandez will lead the expansion of global cosmeceutical ... cosmeceutical and skin care experience having spent the last 25 years working in ...
(Date:8/29/2015)... Avondale, AZ (PRWEB) , ... August 30, 2015 , ... ... Community College (EMCC), one of the 10 regionally accredited Maricopa Community Colleges ... employers to network with college students pursuing employment information and opportunities. , The Expo ...
(Date:8/29/2015)... ... August 29, 2015 , ... It can ... protection against dribbled urine and sweat. "In order to prevent these problems, I ... EASY ACCESS DRYNESS ENHANCED MEN'S UNDERGARMENT provides optimal support for a male’s crotch. ...
(Date:8/29/2015)... New York, NY (PRWEB) , ... August 29, 2015 , ... ... the unofficial end of summer (which astronomically, officially ends on September 22nd this year). ... no summer-induced cyber security hangovers linger on which could prove far more costly than ...
(Date:8/29/2015)... ... August 29, 2015 , ... The popular television program VOICES ... recently announced that it will be devoting an entire short segment to the subject ... people around the globe on a daily basis, but recent advancements in medical science ...
Breaking Medicine News(10 mins):Health News:NPI Executive Vice President Leads Cosmeceutical Expansion 2Health News:Estrella Mountain Community College Expo Offers ‘One-Stop’ for Employers and Students Seeking Internships, Jobs, Careers and Service Learning Opportunities 2Health News:Modified Men’s Underwear Promote More Comfort and Hygiene - Designed by InventHelp Client (LGI-1968) 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 2Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 3Health News:Business Cyber Security – Come Out of the Summer with a Clean Slate 4
... The International Union for Health Promotion and Education (IUHPE) ... pleased to release today special, complementary peer-reviewed journals containing ... of global capacity in health promotion and health education. ... (Vol. 36, No. 3, June 2009), and IUHPE,s journal, ...
... nation,s leading supplier of replacement medical repair parts for hospital ... Chamber of Commerce,s "Entrepreneur of the Year" award for 2009. ... Ohio Chamber out of over 350 nominations statewide. Each ... submit a company for consideration and PartsSource was announced as ...
... Pharma announced today a new study recently published that ... high strength topical antiperspirant with 15% aluminum chloride and ... with moderate-to-severe hyperhidrosis (excessive sweating). The study, conducted by ... the Department of Dermatology at Saint Louis University ...
... Inc. (Nasdaq: NYER ) reported results for the ... third quarter of fiscal 2009 increased $1.3 million or 7.5% ... comparable quarter in the prior year. The increase in ... pharmacies over the past 12 months. Revenues slightly decreased ...
... Inverness Medical Innovations, Inc. (NYSE: IMA ), ... of their health at home through the merger of ... will attend the Deutsche Bank 34th Annual Health Care ... at the InterContinental Boston. Ron Zwanziger, Chief Executive ...
... May 15 Within weeks, the University of ... campus that will provide a springboard for new discoveries, ... wise investment for U-M,s future.U-M,s purchase of the former ... North Campus will be completed on June 16, said ...
Cached Medicine News:Health News:Special journal issues released on global health promotion and health education 2Health News:U.S. Study Shows Significant Improvement for Patients Suffering from Excessive Sweating with Topical Antiperspirant 2Health News:Nyer Medical Group, Inc. Reports Revenues of $18.6 Million for the Quarter Ended March 31, 2009 2Health News:Nyer Medical Group, Inc. Reports Revenues of $18.6 Million for the Quarter Ended March 31, 2009 3Health News:Nyer Medical Group, Inc. Reports Revenues of $18.6 Million for the Quarter Ended March 31, 2009 4Health News:Nyer Medical Group, Inc. Reports Revenues of $18.6 Million for the Quarter Ended March 31, 2009 5Health News:Inverness Medical Innovations to Present at the Deutsche Bank 34th Annual Health Care Conference on May 19, 2009 2Health News:U-M Purchase of Former Pfizer Facility Nears Completion, Paving the Way For Research Expansion and Job Creation 2
(Date:8/28/2015)... 2015  CytomX Therapeutics, Inc., a biopharmaceutical company developing ... the filing of a registration statement on Form S-1 ... to a proposed initial public offering of its common ... the price range for the offering have not yet ... under the symbol "CTMX" on the NASDAQ Global Market. ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... report to their offering. Originally discovered ... as Yoshitomi Pharmaceutical Industries, Ltd) as an inflammatory ... by Senju Pharmaceutical Co., Ltd under the trade ...
(Date:8/28/2015)... DUBLIN , Aug. 28, 2015 ... ) has announced the addition of the ... Capacity and Production" report to their offering. ... Survey of Biopharmaceutical Manufacturing Capacity and Production is ... contract manufacturing organizations, current and projected future capacity ...
Breaking Medicine Technology:CytomX Files Registration Statement for Proposed Initial Public Offering 2Investigation Report on China's Pranoprofen Market, 2010-2019 212th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: